WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 4401 Infant (under 12 months) mortality rate: 412
GDP / capita (US$): 1'3951 Child (under 5 years) mortality rate: 582

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 22'925  22'294  21'679  21'080  20'496  15'745  11'546  8'747 
Births 797  781  765  749  735  648  524  389 
Surviving infants 768  751  735  719  704  604  469  345 
Pop. less than 5 years 3'606  3'529  3'454  3'381  3'316  2'841  2'113  1'647 
Pop. less than 15 years 9'718  9'529  9'341  9'150  8'966  7'164  5'211  4'054 
Female 15-49 years 5'497  5'317  5'143  4'976  4'813  3'609  2'627  1'915 

Number of reported case

(Click for retrospective incidence data for Madagascar)
Diphtheria 12  252  227 
Japanese encephalitis
Measles 35'256  14'459  119'679 
Mumps 12 
Pertussis 19  33  369  255  3'880  1'333  32'457 
Polio* 39  68 
Rubella 131  110  196  157  193 
Rubella (CRS)
Tetanus (neonatal) 43  13  208 
Tetanus (total) 556  490  728  212  54  208  842 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Madagascar)
Vaccine year result method % card seen                                                
BCG 2011  74     46  77  78  82  81  87  99*  98  21 
DTP1 2011  80     46  96  97  96  94  96  86 
DTP3 2011  63     46  90  86  89  85  89  80  71  48 
HepB_BD         
HepB3 2011  63     46  90  86  89  85  89 
Hib3 2011  63     46  90  86  89  85  89 
JapEnc         
MCV 2011  62     46  86  85  85  88  85  81  57 
MCV2         
PCV1          95  65 
PCV3          92 
Pol3 2011  63     46  88  86  88  85  89  81  69 
Rota1         
Rota_last         
Rubella1         
TT2plus          63  59  62  58  61  40  31 
PAB         
VAD1          91  93 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Madagascar)
BCG 77  78  82  76  78  72  67  21 
DTP1 80  80  80  78  80  74  71 
DTP3 74  70  73  70  77  57  46 
HepB3 74  70  73  70  77 
HepB_BD
Hib3 74  70  73  71  77 
MCV 63  61  62  66  63  57  47 
MCV2
PAB 78  78  78  76  76  58  45 
PCV3 92 
Pol3 73  71  73  70  76  58  46 
Rota_last

Number of districts in the country 112  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 45
From 80 to 89% 31
From 50 to 79% 24
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 9 years; +1, +5 months;
Measles 9 months; Yes
OPV Birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes From April 2014
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2010-2015  2011-2015  2011-2015  2011-2015  2010-2014  2007-2011   
Nº of districts with microplans that include activities to raise immunization coverage number 112  112  112  111  111  111  111 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  Yes  No       

System performance

Total Nº districts in country number 112  112  112  111  111  111  111 
Nº districts with DTP3 coverage >=80% number 85  76  86  65  76  78  19 
% of districts with DTP3 coverage >=80% From 0 to 100% 76  68  77  59  68  70  17 
Nº districts with measles (MCV1) coverage >=95% number 34  25  21  41  30  44   
% of districts with MCV1 coverage >=95% From 0 to 100% 30  22  19  37  27  40   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 21  8,54% Yes tous les vaccins et 51% Yes vaccins traditionnels  10  26 

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.